Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats

Journal of Neuroscience

Volumn 24, Issue 15, 2004, Pages 3752-3761

  Jones, T Bucky ^a   Ankeny, Daniel P ^a   Guan, Zhen ^a   McGaughy, Violeta ^a   Fisher, Lesley C ^a   Basso, D Michele ^a   Popovich, Phillip G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; EAE; Inflammation; Myelin basic protein; Neuroprotection; Vaccine

Indexed keywords

MYELIN BASIC PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFECTOR CELL; FEMALE; FUNCTIONAL DISEASE; LOCOMOTION; LYMPHOCYTE FUNCTION; MACROPHAGE ACTIVATION; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; RATING SCALE; RUBROSPINAL TRACT; SPINAL CORD INJURY; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; IMMUNIZATION, PASSIVE; MOTOR ACTIVITY; MYELIN BASIC PROTEINS; MYELIN SHEATH; MYELITIS; RATS; RATS, INBRED LEW; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; T-LYMPHOCYTES; VACCINATION;

EID: 1942521774     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0406-04.2004     Document Type: Article

References (74)

1. Ahmed Z, Baker D, Cuzner ML (2003) Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat. J Neuroimmunol 140:109-117.
2. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassman H, Kollias G, Probert L (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice. Am J Pathol 153:801-813.
3. Anderton SM, van der ZR, Goodacre JA (1993) Inflammation activates self hsp60-specific T cells. Eur J Immunol 23:33-38.
4. Angelov DN, Waibel S, Guntinas-Lichius O, Lenzen M, Neiss WF, Tomov TL, Yoles E, Kipnis J, Schori H, Reuter A, Ludolph A, Schwartz M (2003) Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100:4790-4795.
5. Antel JP, Williams K, Blain M, McRea E, McLaurin J (1994) Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor. Ann Neurol 35:341-348.
6. Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL (1997) Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA 94:599-603.
7. Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
8. Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256.
9. Basso DM, Beattie MS, Bresnahan JC (2002) Descending systems contributing to locomotor recovery after mild or moderate spinal cord injury in rats: experimental evidence and a review of literature. Restor Neurol Neurosci 20:189-218.
10. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12:1539-1546.
11. Batchelor PE, Liberatore GT, Wong JYF, Porritt MJ, Frerichs F, Donnan GA, Howells DW (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19:1708-1716.
12. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94:10873-10878.
13. Behrmann DL, Bresnahan JC, Beattie MS, Shah BR (1992) Spinal cord injury produced by consistent displacement of the cord in rats: behavioral and histologic analysis. J Neurotrauma 9:197-217.
14. Bieber AJ, Kerr S, Rodriguez M (2003) Efficient central nervous system remyelination requires T cells. Ann Neurol 53:680-684.
15. Bielekova B, Muraro PA, Golestaneh L, Pascal J, McFarland HF, Martin R (1999) Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J Neuroimmunol 100:115-123.
16. Birnbaum G, Kotilinek L, Miller SD, Raine CS, Gao YL, Lehmann PV, Gupta RS (1998) Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J Neuroimmunol 90:149-161.
17. Bitsch A, Kuhlmann T, Da Costa C, Bunkowski S, Polak T, Bruck W (2000) Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia 29:366-375.
18. Chan CC, Mochizuki M (1999) Sympathetic ophthalmia: an autoimmune ocular inflammatory disease. Springer Semin Immunopathol 21:125-134.
19. Chang JT, Shevach EM, Segal BM (1999) Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J Exp Med 189:969-978.
20. Check E (2002) Nerve inflammation halts trial for Alzheimer's drug. Nature 415:462.
21. Chen Z, Ljunggren HG, Zhu SW, Winblad B, Zhu J (2004) Reduced susceptibility to kainic acid-induced excitoxicity in T-cell deficient CD4/ CD8(-/-) and middle-aged C57BL/6 mice. J Neuroimmunol 146:33-38.
22. Conlon P, Oksenberg JR, Zhang J, Steinman L (1999) The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol Dis 6:149-166.
23. Fee D, Crumbaugh A, Jacques T, Herdrich B, Sewell D, Auerbach D, Piaskowski S, Hart MN, Sandor M, Fabry Z (2003) Activated/effector CD4 T cells exacerbate acute damage in the central nervous system following traumatic injury. J Neuroimmunol 136:54-66.
24. Fehlings MG, Tator CH (1995) The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 132:220-228.
25. Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF, Ben Nun A, Schwartz M (2001) Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 21:136-142.
26. Gimsa U, Peter SV, Lehmann K, Bechmann I, Nitsch R (2000) Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells. Brain Pathol 10:365-377.
27. Giuliani F, Goodyer CG, Antel JP, Yong VW (2003) Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 171:368-379.
28. Gonzalez R, Glaser J, Liu MT, Lane TE, Keirstead HS (2003) Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol 184:456-463.
29. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ (1988a) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379-394.
30. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorenson FB, Vesterby A, West MJ (1988b) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881.
31. Hauben E, Butovsky O, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Leibowitz-Amit R, Pevsner E, Akselrod S, Neeman M, Cohen IR, Schwartz M (2000a) Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 20:6421-6430.
32. Hauben E, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Akselrod S, Neeman M, Cohen IR, Schwartz M (2000b) Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355:286-287.
33. Hauben E, Agranov E, Gothilf A, Nevo U, Cohen A, Smirnov I, Steinman L, Schwartz M (2001a) Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J Clin Invest 108:591-599.
34. Hauben E, Ibarra A, Mizrahi T, Barouch R, Agranov E, Schwartz M (2001b) Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc Natl Acad Sci USA 98:15173-15178.
35. Hayes KC, Hull TC, Delaney GA, Potter PJ, Sequeira KA, Campbell K, Popovich PG (2002) Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma 19:753-761.
36. Held W, Meyermann R, Qin Y, Mueller C (1993) Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats. J Autoimmun 6:311-322.
37. Hickey WF, Cohen JA, Burns JB (1987) A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol 109:272-281.
38. Hofstetter HH, Sewell DL, Liu F, Sandor M, Forsthuber T, Lehmann PV, Fabry Z (2003) Autoreactive T cells promote post-traumatic healing in the central nervous system. J Neuroimmunol 134:25-34.
39. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025-1033.
40. Ibarra A, Correa D, Willms K, Merchant MT, Gui, zar-Sahagun G, Grijalva I, Madrazo I (2003) Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res 979:165-178.
41. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG (2002) Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 22:2690-2700.
42. Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L (2000) Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat Med 6:1176-1182.
43. Kil K, Zang YCQ, Yang D, Markowski J, Fuoco GS, Vendetti GC, Rivera VM, Zhang JZ (1999) T-cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol 98:201-207.
44. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M (2002) Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA 99:15620-15625.
45. Koller H, Siebler M, Hartung H-P (1997) Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog Neurobiol 52:1-26.
46. Mason JL, Suzuki K, Chaplin DD, Matsushima GK (2001) Interleukin-1beta promotes repair of the CNS. J Neurosci 21:7046-7052.
47. Mautes AE, Noble LJ (2000) Co-induction of HSP70 and heme oxygenase-1 in macrophages and glia after spinal cord contusion in the rat. Brain Res 883:233-237.
48. Medana I, Martinic MA, Wekerle H, Neumann H (2001) Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 159:809-815.
49. Midha R, Fehlings MG, Tator CH, Saint-Cyr JA, Guha A (1987) Assessment of spinal cord injury by counting corticospinal and rubrospinal neurons. Brain Res 410:299-308.
50. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T-cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-55.
51. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985.
52. Olsson T, Diener P, Ljungdahl A, Hojeberg B, van der Meide PH, Kristensson K (1992) Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmun 13:117-126.
53. Olsson T, Sun JB, Solders G, Xiao BG, Hojeberg B, Ekre HP, Link H (1993) Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J Neurol Sci 117:130-139.
54. Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle H (1990) Myelin basic protein-specific T lymphocyte fines from MS patients and healthy individuals. Neurology 40:1770-1776.
55. Popovich PG, Stokes BT, Whitacre CC (1996) Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res 45:349-363.
56. Popovich PG, Wei P, Stokes BT (1997) The cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464.
57. Prochazka M, Voltnerova M, Stefan J (1971) Studies of immunological reactions after brain injury. II. Antibodies against brain tissue lipids after blunt head injury in man. Int Surg 55:322-326.
58. Puga Yung GL, Le TD, Roord S, Prakken B, Albani S (2003) Heat shock proteins (HSP) for immunotherapy of rheumatoid arthritis (RA). Inflamm Res 52:443-451.
59. Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce disseminated encephalomyelitis in monkeys. J Exp Med 58:39-53.
60. Rivlin AS, Tator CH (1977) Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47:577-581.
61. Schwartz M, Kipnis J (2001) Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med 7:252-258.
62. Schwartz M, Moalem G (2001) Beneficial immune activity after CNS injury: prospects for vaccination. J Neuroimmunol 113:185-192.
63. Schwartz M, Cohen I, Lazarov-Spiegler O, Moalem G, Yoles E (1999) The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J Mol Med 77:713-717.
64. Serpe CJ, Kohm AP, Huppenbauer CB, Sanders VM, Jones KJ (1999) Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodefiecient (scid) mice. J Neurosci 19:1-5.
65. Shieh JY, Leong SK, Wong WC (1983) Origin of the rubrospinal tract in neonatal, developing, and mature rats. J Comp Neurol 214:79-86.
66. Steinman L (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299-302.
67. Steinman L (2003) Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J Exp Med 197:1065-1071.
68. Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127-136.
69. Strominger RN, McGiffen JE, Strominger NL (1987) Morphometric and experimental studies of the red nucleus in the albino rat. Anat Rec 219:420-428.
70. Swanborg RH, Shulman S (1970) Purification of an organ-specific thermo-stable antigen found in bovine brain. Immunology 19:31-40.
71. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Eng J Med 338:278-285.
72. Vikman KS, Hill RH, Backstrom E, Robertson B, Kristensson K (2003) Interferon-gamma induces characteristics of central sensitization in spinal dorsal horn neurons in vitro. Pain 106:241-251.
73. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, Hafler DA (1994) Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 152:5581-5592.
74. Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A, Kuchroo V, Cohen IR, Weiner H, Schwartz M (2001) Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 21:3740-3748.